UNSPSC 51293203: Pheniprazine

This classification denotes a monoamine oxidase inhibitor with the molecular formula C9H14N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 37VKD7067M, chemically known as hydrazine, (.alpha.-methylphenethyl)-, monohydrochloride but generally known as pheniprazine, which bears US NIH Compound Identifier 5929. European Medicines Agency schedules Pheniprazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09767MIG. The term PHENIPRAZINE is an International Non-Proprietary Name.

UNSPSC 51293203 Pheniprazine is a Commodity code that in recent state and local procurement activity does not appear to map to actual buying patterns. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS for Naloxone and Safe Drug Deactivation Systems—involves naloxone (a medication used to reverse opioid overdose) and drug deactivation equipment, neither of which aligns with pheniprazine's pharmaceutical scope as an antidepressant or monoamine oxidase inhibitor. The mismatch suggests either a data-entry error in the county's procurement tagging or a fundamental misalignment between the UNSPSC assignment and the goods actually being sought. State and local procurement offices occasionally apply incorrect commodity codes, particularly when sourcing medical and pharmaceutical supplies through general health or emergency-response channels rather than pharmaceutical specialty categories.

The Seminole County procurement represents the only recent state and local opportunity visible under this code. The county issued an IFB on June 30, 2026, with a response deadline of July 26, 2023—a date inconsistency that suggests the posting may be archival or the record contains transcription errors. Seminole County required 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract term was two years with an optional one-year renewal. Given the lack of verifiable recent activity under this code and the apparent miscoding of the single visible opportunity, the code shows little actionable procurement signal for vendors targeting state and local health or pharmaceutical supply work.